Company / Net Income
Adaptive Biotechnologies Corp Net Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$59.5M
FY2025
5-year range
-$225.3M / -$59.5M
FY2021-FY2025
Trend
+62.7%
vs FY2024
Sector context
#84 of 216
Health Care
What the data says
At -$59M, Adaptive Biotechnologies Corp's net income ranks #84 of 216 in the Health Care sector. Net Income has fluctuated over the past 9 years, ranging from -$225M in FY2023 to -$43M in FY2017.
Based on SEC 10-K filings.
-$59M in FY2025.
Improved from -$225M to -$59M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#84 of 216 in Health CareTop 39% of 216This company -$59.5M Sector average $454.1M
▼
-113.1% below sector average
Key checks
Key Insights
- In FY2025, net income increased 62.7% year-over-year.
- Ranks #84 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2017.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$59.5M | +62.7% |
| FY2024 | -$159.5M | +29.2% |
| FY2023 | -$225.3M | -12.5% |
| FY2022 | -$200.2M | +3.4% |
| FY2021 | -$207.3M | -41.8% |
| FY2020 | -$146.2M | -113.1% |
| FY2019 | -$68.6M | -47.7% |
| FY2018 | -$46.4M | -8.4% |
| FY2017 | -$42.8M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026